- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: non-anthracycline trastuzumab
Total 1305 results
-
Eric Winer, MDMassachusetts General Hospital; Yale University; Dana-Farber Cancer Institute; Beth... and other collaboratorsCompletedBreast CancerUnited States
-
Genentech, Inc.Completed
-
Dartmouth-Hitchcock Medical CenterNational Cancer Institute (NCI)Completed
-
GlaxoSmithKlineWithdrawn
-
National Cancer Institute (NCI)TerminatedRecurrent Salivary Gland Cancer | Stage IVA Salivary Gland Cancer | Stage IVB Salivary Gland Cancer | Stage IVC Salivary Gland Cancer | High-grade Salivary Gland Mucoepidermoid Carcinoma | Salivary Gland Acinic Cell Tumor | Salivary Gland Adenocarcinoma | Salivary Gland Poorly Differentiated CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Fallopian Tube Cancer | Bone Metastases | Lung Metastases | Stage III Renal Cell Cancer | Liver Metastases | Recurrent Thyroid Cancer | Stage IV Follicular Thyroid Cancer | Stage IV Papillary Thyroid Cancer | Inflammatory Breast Cancer | Metastatic Transitional Cell Cancer of the... and other conditionsUnited States
-
Harold J. Burstein, MD, PhDBristol-Myers Squibb; Massachusetts General Hospital; Dana-Farber Cancer Institute and other collaboratorsCompleted
-
Hellenic Oncology Research GroupUniversity Hospital of CreteTerminated
-
National Cancer Institute (NCI)CompletedCancerUnited States
-
National Cancer Institute (NCI)CompletedColorectal CancerUnited States
-
National Cancer Institute (NCI)CompletedMetastatic OsteosarcomaUnited States
-
National Cancer Institute (NCI)TerminatedHER2-positive Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Recurrent Breast CancerUnited States
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
National Cancer Institute (NCI)CompletedMale Breast Cancer | Stage IV Breast Cancer | Recurrent Breast CancerUnited States
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
UNICANCERTerminated
-
National Cancer Institute (NCI)CompletedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)TerminatedInflammatory Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Cardiac ToxicityUnited States
-
National Cancer Institute (NCI)CompletedMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter | Recurrent Bladder Cancer | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Squamous Cell Carcinoma of the BladderUnited States
-
PfizerCompleted
-
PfizerCompleted
-
Infinity Pharmaceuticals, Inc.TerminatedBreast Cancer | Metastatic Breast Cancer | HER2 Positive Breast Cancer | Cancer of the BreastUnited States, Spain
-
M.D. Anderson Cancer CenterBayerCompleted
-
University of KansasNovartisWithdrawn
-
University of Michigan Rogel Cancer CenterGenentech, Inc.CompletedHER-2 Positive Metastatic Breast CancerUnited States
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedT-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid TumorsSarcoma | Breast Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
SanofiCompleted
-
European Organisation for Research and Treatment...CompletedBreast CancerBelgium, Netherlands, France
-
Zhimin ShaoRoche Pharma AGUnknownHER-2 Positive Breast CancerChina
-
SanofiCompleted
-
University of MiamiAventis PharmaceuticalsCompletedBreast CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI)Completed
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
National Cancer Institute, NaplesWithdrawn
-
M.D. Anderson Cancer CenterGenentech, Inc.Completed
-
Auxilio Mutuo Cancer CenterUnknownInfiltrating Duct and Lobular Carcinoma In Situ | Invasive Lobular Breast Carcinoma | Inflammatory Breast CarcinomaPuerto Rico
-
Bristol-Myers SquibbCompletedBreast CancerAustralia, Hungary, Canada, United Kingdom, Belgium
-
National Cancer Institute, NaplesCompletedMetastatic Breast Cancer
-
The University of Texas Health Science Center at...National Cancer Institute (NCI)Withdrawn
-
SanofiCompleted
-
Emory UniversityCompletedBreast CancerUnited States
-
Northwestern UniversityNational Cancer Institute (NCI)Withdrawn
-
BiogenCompleted
-
Centre Oscar LambretTerminatedBreast Cancer | Metastasis | Sur-expressing Her2-neuFrance
-
The Netherlands Cancer InstituteCompletedBreast Cancer | HER2 PositiveNetherlands
-
Shandong Cancer Hospital and InstituteUnknownLiver Diseases | Neoplasms by Histologic Type | Neoplasms by Site | Adenocarcinoma | Carcinoma | Neoplasms, Glandular and Epithelial | Digestive System Neoplasms | Carcinoma, Hepatocellular | Liver Neoplasms | HBV | PHENYTOIN/SORAFENIB [VA Drug Interaction] | DOXORUBICIN/TRASTUZUMAB [VA Drug Interaction]China
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Accelerated Community Oncology Research NetworkAventis PharmaceuticalsCompletedBreast NeoplasmUnited States
-
Hellenic Oncology Research GroupUniversity Hospital of CreteTerminated
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)Completed